Residual Bootstrap Test for Interactions in Biomarker Threshold Models with Survival Data

Many new treatments in cancer clinical trials tend to benefit a subset of patients more. To avoid unnecessary therapies and failure to recognize beneficial treatments, biomarker threshold models are often used to identify this subset of patients. We are interested in testing the treatment–biomarker...

Ausführliche Beschreibung